Cytokinetics, Inc. (CYTK)
60.32
-1.28
(-2.08%)
USD |
NASDAQ |
Dec 10, 16:00
60.32
0.00 (0.00%)
After-Hours: 17:32
Cytokinetics Profit Margin (Quarterly): -15.81K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Jasper Therapeutics, Inc. | -- |
| Lantheus Holdings, Inc. | 7.23% |
| Bristol Myers Squibb Co. | 17.96% |
| Pfizer Inc. | 21.32% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -55.58% |
| Return on Invested Capital | -120.6% |
| Gross Profit Margin (Quarterly) | -38.38% |
| Operating Margin (Quarterly) | -8.61K% |
| Return on Net Operating Assets | -497.8% |